Two-step process leads to cell immortalisation and cancer
New research, has studied the immortalisation process using genome-engineered cells...
List view / Grid view
New research, has studied the immortalisation process using genome-engineered cells...
A research team have studied how alterations in a tumour depend on each other and how these dependencies determine cancer evolution...
Scientists have described a new type of test that can detect genetic mutations in minute amounts of DNA...
A report published has identified the prospects of immunotherapy treatments...
Scientists have made progress in the development of products that improve mitochondrial function...
Researchers have identified a new toxin, botulinum neurotoxin type X (BoNT/X), that has the potential to open up a new field of toxin therapeutics...
Peer-reviewed publication on new strategies to target misfolded protein aggregates at various steps of protein production and processing...
Targeting HER3 could cripple metastatic cancers that have spread to the brain...
Included in this Stem Cells In-Depth Focus: Translating discoveries into therapies; The key to successful manufacturing of patient-specific cell therapies; Interview with Alessandro Prigione and James Adjaye...
Included in this issue: Technology convergence improves testing; Screening; Stem Cells; Targets; Mass Spectrometry; and Therapeutics in Alzheimer's disease...
An experimental treatment in mice allows the reprogramming of blood cells in order to promote the healing process of cutaneous wounds...
Investments are now being made to roll out this innovation across healthcare and broaden the scope of the research in this field.
A cancer drug for patients with certain types of leukaemia and lymphoma can also prevent reactions to some of the most common airborne allergens, according to a recent Northwestern Medicine study. The promising data from this pilot study could have greater implications for adults with food allergies.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing 15 new Research Training Groups to further support early research...
Licensing agreement will expand Oxford Genetics growing bio-therapeutic discovery, design and development service business.